The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) |
93.866 |
PAR-21-220 |
| NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) |
93.866 |
PAR-21-217 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-22-011 |
| Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) |
93.307, 93.313, 93.847, 93.867 |
PA-21-232 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-22-010 |
| Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional) |
93.279 |
RFA-DA-22-012 |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional) |
93.242, 93.853 |
RFA-MH-21-226 |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) |
93.279 |
RFA-DA-22-030 |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional) |
93.242, 93.853 |
RFA-MH-21-225 |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) |
93.279 |
RFA-DA-22-024 |
| Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.313, 93.853, 93.989 |
PAR-21-230 |
| Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional) |
93.242, 93.313, 93.398, 93.847, 93.853, 93.989 |
RFA-TW-21-004 |
| Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) |
93.279 |
RFA-DA-22-005 |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-22-007 |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) |
93.310 |
RFA-RM-21-016 |
| NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) |
93.853 |
PAR-21-237 |
| Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PAR-21-155 |
| Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
93.172, 93.173, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.865, 93.866, 93.867 |
PAR-21-154 |
| Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical |
93.847 |
RFA-DK-21-012 |
| Office of Postsecondary Education (OPE): Higher Education Programs (HEP): Minority Science and Engineering Improvement Program (MSEIP) Assistance Listing Number 84.120A |
84.120 |
ED-GRANTS-052121-001 |
| T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-22-001 |
| SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) |
93.142 |
RFA-ES-21-005 |
| Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-016 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) |
93.273, 93.279 |
PA-21-180 |
| Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
93.242, 93.853 |
PA-21-219 |
| Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) |
93.279 |
PA-21-205 |
| Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) |
93.113, 93.273, 93.279, 93.286, 93.853 |
PAR-21-168 |
| NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) |
93.242 |
PA-21-235 |
| NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required) |
93.853 |
PAR-21-236 |
| BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-024 |
| Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-007 |
| BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-023 |
| NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) |
93.242 |
PAR-21-228 |
| Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-039 |
| Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 |
93.847 |
RFA-DK-21-011 |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
93.853 |
PAR-21-224 |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-004 |
| Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
93.121, 93.351, 93.865 |
PAR-21-229 |
| Human Milk as a Biological System (R01 Clinical Trial Optional) |
93.865 |
RFA-HD-22-020 |
| NeuroNEXT Clinical Trials (U01 Clinical Trial Optional) |
93.853 |
PAR-21-223 |
Search Results 2081-2120 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
